 |
|
|
|
|
|
|
|
|
|
|
|
1 to 11 of 11 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
T E. on PAPER: Tweedie D. et al., 2007, Recommendation Only. 21 Nov 2007.
|
|
|
 |
|
|
T E. on PAPER: Wang Q. et al., 2005, Recommendation Only. 21 Nov 2007.
|
|
|
|
|
|
T E. on NEWS: San Diego: Oligomers Live Up to Bad Reputation, Part 1, The work of Shankar and colleagues provides new evidence supporting the concept that soluble Aβ... 18 Nov 2007.
|
|
|
|
|
|
T E. on NEWS: Tau Toxicity—Tangle-free But Tied to Inflammation, Anti-inflammatories for AD—Time for Consideration of the Next Generation?
This news... 7 Feb 2007.
|
|
|
|
|
|
T E. on PAPER: Yamamoto M. et al., 2007, These new findings support the idea that glial interferon-γ and TNFα enhance Aβ deposition... 31 Jan 2007.
|
|
|
|
|
|
T E. on PAPER: Jekabsone A. et al., 2006, This article provides evidence implicating excess TNFα and microglial activation in the... 19 Sep 2006.
|
|
|
|
|
|
T E. on PAPER: Lio D. et al., 2006, This study joins a recent report from Australia (Laws et al., 2005) that associates variations... 28 Aug 2006.
|
|
|
|
|
|
T E. on PAPER: Takeuchi H. et al., 2006, This article joins an increasing body of scientific evidence which suggests that TNF-alpha... 28 Aug 2006.
|
|
|
|
|
|
T E. on PAPER: Ramos EM. et al., 2006, This article, resulting from the collaboration between both the University of Washington and the... 26 Aug 2006.
|
|
|
|
|
|
T E. on PAPER: Stellwagen D. et al., 2006, I agree with the comments of Paul Coleman and David Small. Changes in TNF-mediated synaptic... 13 Jun 2006.
|
|
|
|
|
|
Trushina E. on PAPER: Yu W. et al., 2005, It is always fascinating to think why, in neurodegenerative disorders characterized by the loss... 29 Jan 2005.
|
|
|
|
|
|
|
1 to 11 of 11 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
Check out our upcoming Webinar: 
